KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Share-based Compensation (2016 - 2025)

Bausch Health Companies' Share-based Compensation history spans 17 years, with the latest figure at $84.0 million for Q4 2025.

  • For Q4 2025, Share-based Compensation rose 95.35% year-over-year to $84.0 million; the TTM value through Dec 2025 reached $216.0 million, up 44.0%, while the annual FY2025 figure was $216.0 million, 44.0% up from the prior year.
  • Share-based Compensation for Q4 2025 was $84.0 million at Bausch Health Companies, up from $43.0 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $84.0 million in Q4 2025 and bottomed at $26.0 million in Q2 2022.
  • The 5-year median for Share-based Compensation is $33.0 million (2021), against an average of $37.6 million.
  • The largest annual shift saw Share-based Compensation decreased 19.51% in 2024 before it soared 95.35% in 2025.
  • A 5-year view of Share-based Compensation shows it stood at $33.0 million in 2021, then increased by 6.06% to $35.0 million in 2022, then fell by 17.14% to $29.0 million in 2023, then soared by 48.28% to $43.0 million in 2024, then surged by 95.35% to $84.0 million in 2025.
  • Per Business Quant, the three most recent readings for BHC's Share-based Compensation are $84.0 million (Q4 2025), $43.0 million (Q3 2025), and $46.0 million (Q2 2025).